Morning Overview on MSN
Prodrug lipid nanoparticle delivers IDO inhibitor and mRNA to fight tumors
Engineers at the University of Pennsylvania have built a lipid nanoparticle that chemically fuses an IDO-pathway inhibitor ...
Engineers at the University of Pennsylvania have developed a new type of lipid nanoparticle (LNP) that could one day serve as ...
Clinical outcomes of patients with early-stage epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer who underwent reflex molecular testing. This is an ASCO Meeting Abstract from ...
NewLink Genetics (NASDAQ: NLNK) and Incyte Corporation (NASDAQ: INCY) are racing a new class of drugs through clinical trials, and if these trials are successful, these new drugs may change how ...
Because foetuses contain 'foreign' paternal proteins, they must be protected from destruction by maternal T cells during pregnancy. An enzyme called indoleamine 2,3 dioxygenase (IDO) is involved in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results